A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: intermediate-term results

The Journal of Thoracic and Cardiovascular Surgery
S M PhamB P Griffith

Abstract

Between January 1, 1989, and December 31, 1994, we have treated 122 primary heart recipients with FK 506 (group I) and 121 with cyclosporine (group II). Fifty patients in the cyclosporine (CyA) group received no lympholytic induction (CyA alone) and 71 others received lympholytic induction with either rabbit antithymocyte globulin or OKT3 (CyA+LI). The mean follow-up was longer in the FK 506 group than in the CyA groups (3.2 +/- 1.3 vs 2.3 +/- 1.8 years; p< 0.01). Patient survival did not differ on the basis of the type of immunosuppression used. At 3 months after transplantation, the freedom from rejection in the FK 506 group was higher than that of the CyA-alone group (47% vs 22%, p < 0.01) but similar to that of the CyA+LI group (47% vs 53%). The linearized rejection rate (episodes/100 patient-days) of the FK 506 group (0.09 episodes) was lower (p < 0.05) than that of the CyA-alone group (0.26) and the CyA+LI group (0.13). The requirement for pulsed steroids to treat rejection was less in common in the FK 506 group than in either CyA group. Eighteen patients in the CyA group had refractory rejections; all resolved with FK 506 rescue. Two patients in the FK 506 group had refractory rejection that resolved with total lymphoid ...Continue Reading

Citations

Jul 3, 1998·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·V J CanzanelloR A Krom
Jan 24, 1998·Herz·B M MeiserB Reichart
Apr 7, 2006·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·M LoebeD J Hamilton
Jan 5, 2001·Current Treatment Options in Cardiovascular Medicine·S V Pamboukian, M R Costanzo
Nov 12, 2003·Pharmacology & Therapeutics·Farzad Moien-AfshariIsmail Laher
Sep 2, 1998·The American Journal of Cardiology·G Z HerzbergW W Lai
Aug 24, 2000·The American Journal of Cardiology·V KlaussH Mudra
Jul 8, 2000·European Journal of Pharmacology·G RomanoE Bartoli
May 18, 2000·Transplantation Proceedings·H Valantine
Sep 10, 2003·Transplantation Proceedings·M G Crespo-Leiro
Sep 2, 1998·Transplantation Proceedings·A Cheung, A H Menkis
Sep 29, 1999·Transplantation Proceedings·R Shapiro
Apr 25, 2000·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·M H YamaniJ B Young
Jul 13, 2001·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·D O TaylorA L Gass
Feb 13, 2001·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·D A BaranA L Gass
Sep 17, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Hugues JeanmartLouis P Perrault
Apr 12, 2003·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Louis P PerraultPaul M Vanhoutte
Jul 23, 2003·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Bernard CantinMichael C Y Chan
Mar 17, 2004·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Jeffrey Rand RubelJohn Adams Jarcho
Apr 8, 1999·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·B M MeiserB Reichart
May 5, 1999·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·D O TaylorP VanVeldhuisen
Jun 11, 1999·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·D R OnsagerR B Love
Dec 22, 1999·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·O TagusariB P Griffith
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·R CoralesR K Avery
Jan 5, 2002·International Journal of Paediatric Dentistry·B WondimuT Modéer
Jul 31, 2002·Heart Disease·Shelley Hankins, Donna Mancini
Apr 25, 2000·Annual Review of Medicine·M Weis, W von Scheidt
Sep 9, 2004·Japanese Heart Journal·Ruzheng LiAtsushi Amano
Nov 24, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·S M Tsunoda, F T Aweeka
May 23, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jignesh K Patel, Jon A Kobashigawa
Dec 20, 2012·Clinical & Developmental Immunology·Kadiyala V RavindraSuzanne T Ildstad
Sep 14, 2014·Critical Reviews in Oncology/hematology·Simon Abi AadElie Mouhayar
Sep 12, 2000·Current Cardiology Reports·I A Smolens, S F Bolling
Feb 15, 2016·Journal of Pharmaceutical and Biomedical Analysis·Adriana Mika, Piotr Stepnowski
Apr 16, 2011·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Rita AllowayNasrullah Undre
May 12, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M GrimmG Laufer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.